References Hui W, Song R, Tao H, Gao Z, Zhu M, Zhang M, et al. Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non-small cell lung cancer: a modelling approach. BMC Cancer. 2023;23:442. Article PubMed PubMed Central Google Scholar Liu L, Bai H, Wang C, Seery S, Wang Z, Duan J, et al. Efficacy and safety of First-Line Immunotherapy combinations for Advanced NSCLC: a systematic review and network Meta-analysis. J Thorac Oncol. 2021;16:1099–117.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Delta Hat
Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
Citation Paola Ghione, Maria Lia Palomba, Anik Patel, Sabela Bobillo, Kevin Deighton, Caron A. Jacobson, Myrna Nahas, Anthony J Hatswell, A Scott Jung, Steve Kanters, Julia Thornton Snider, Sattva S. Neelapu, Maria Teresa Ribeiro, Maurice Alan Brookhart, Herve Ghesquieres, John Radford, John G Gribben; Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma. Blood 2022; blood.2021014375.
Learnings for Health Economics from the Early Stages of the COVID-19 Pandemic
As I write, in March 2020, the world is in the early stages of dealing with a novel strain of coronavirus that emerged in China and spread worldwide. Whilst research is being conducted on and about the virus, the topic of this editorial is not the virus per se, rather a reflection of the implications for our field. I look at how we stand compared with adjacent fields and the implications for health economics (HE).
NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence
Original Research Article First Online: 27 June 2019 Abstract Introduction Health technology assessment (HTA) aims to provide a transparent framework within which normative judgements can be applied for decision making. Such transparency enables the public to understand the rationale for decision making, but conflicts with companies being able to offer commercially sensitive discounts. We investigated how to balance these conflicting ideals.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Delta
Contact Delta, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack